Clinical results
In randomized clinical trials, A1C dropped by an average of 1.2% in intervention groups compared to relatively no change in control groups.
Contain complications
“Each 1% reduction in updated mean HbA1C was associated with reductions in risk of 21% for any end point related to diabetes, 21% for deaths related to diabetes, 14% for myocardial infarction, and 37% for microvascular complications.”